 Robert Rogers
Concepts (176)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Peripheral Arterial Disease | 16 | 2024 | 498 | 3.170 |
Why?
| | Lower Extremity | 8 | 2024 | 444 | 1.350 |
Why?
| | Angioplasty, Balloon | 4 | 2014 | 94 | 1.310 |
Why?
| | Endovascular Procedures | 7 | 2020 | 375 | 1.240 |
Why?
| | Stents | 7 | 2018 | 543 | 1.210 |
Why?
| | Tibial Arteries | 3 | 2017 | 12 | 1.190 |
Why?
| | Ischemia | 3 | 2020 | 416 | 1.000 |
Why?
| | Arterial Occlusive Diseases | 3 | 2011 | 89 | 0.950 |
Why?
| | Natriuretic Peptide, Brain | 4 | 2009 | 105 | 0.940 |
Why?
| | Angiography | 3 | 2024 | 207 | 0.830 |
Why?
| | Coronary Artery Disease | 2 | 2024 | 722 | 0.720 |
Why?
| | Blood Gas Monitoring, Transcutaneous | 1 | 2020 | 3 | 0.650 |
Why?
| | Laser-Doppler Flowmetry | 1 | 2020 | 30 | 0.640 |
Why?
| | Ankle Brachial Index | 1 | 2020 | 37 | 0.640 |
Why?
| | Perfusion Imaging | 1 | 2020 | 63 | 0.630 |
Why?
| | Vascular Surgical Procedures | 5 | 2024 | 341 | 0.600 |
Why?
| | Foot | 1 | 2020 | 100 | 0.590 |
Why?
| | Platelet Aggregation Inhibitors | 3 | 2018 | 485 | 0.570 |
Why?
| | Early Termination of Clinical Trials | 1 | 2018 | 18 | 0.560 |
Why?
| | Sample Size | 1 | 2018 | 126 | 0.540 |
Why?
| | Patient Selection | 2 | 2018 | 691 | 0.510 |
Why?
| | Atherectomy | 2 | 2014 | 37 | 0.500 |
Why?
| | Cerebral Revascularization | 1 | 2015 | 22 | 0.470 |
Why?
| | Carotid Artery Diseases | 1 | 2015 | 64 | 0.460 |
Why?
| | Endarterectomy, Carotid | 1 | 2015 | 55 | 0.460 |
Why?
| | Aspirin | 1 | 2018 | 398 | 0.440 |
Why?
| | Foreign-Body Migration | 1 | 2014 | 32 | 0.410 |
Why?
| | Treatment Outcome | 17 | 2024 | 11365 | 0.410 |
Why?
| | Vascular System Injuries | 1 | 2014 | 77 | 0.390 |
Why?
| | Femoral Artery | 1 | 2014 | 188 | 0.380 |
Why?
| | Vascular Calcification | 1 | 2014 | 112 | 0.370 |
Why?
| | Stroke | 3 | 2018 | 1213 | 0.330 |
Why?
| | Iliac Artery | 1 | 2010 | 57 | 0.310 |
Why?
| | Intermittent Claudication | 3 | 2015 | 122 | 0.310 |
Why?
| | Radiographic Image Enhancement | 1 | 2009 | 57 | 0.300 |
Why?
| | Hypertrophy, Left Ventricular | 1 | 2008 | 120 | 0.270 |
Why?
| | Elasticity Imaging Techniques | 1 | 2008 | 59 | 0.270 |
Why?
| | Coronary Vessels | 1 | 2009 | 251 | 0.260 |
Why?
| | Coronary Angiography | 1 | 2009 | 318 | 0.260 |
Why?
| | Carotid Stenosis | 2 | 2018 | 99 | 0.260 |
Why?
| | Predictive Value of Tests | 5 | 2020 | 2086 | 0.240 |
Why?
| | Humans | 31 | 2024 | 143560 | 0.230 |
Why?
| | Constriction, Pathologic | 3 | 2011 | 246 | 0.230 |
Why?
| | Electrocardiography | 1 | 2008 | 630 | 0.230 |
Why?
| | Image Processing, Computer-Assisted | 1 | 2009 | 772 | 0.220 |
Why?
| | Heart Ventricles | 1 | 2009 | 755 | 0.220 |
Why?
| | Cardiovascular Diseases | 1 | 2016 | 2113 | 0.210 |
Why?
| | Aged | 14 | 2021 | 25322 | 0.190 |
Why?
| | Community Health Services | 2 | 2015 | 234 | 0.190 |
Why?
| | Risk Assessment | 5 | 2021 | 3577 | 0.180 |
Why?
| | Middle Aged | 14 | 2021 | 35342 | 0.180 |
Why?
| | Ulcer | 1 | 2021 | 34 | 0.180 |
Why?
| | Rivaroxaban | 1 | 2024 | 269 | 0.180 |
Why?
| | Hematoma | 1 | 2021 | 55 | 0.180 |
Why?
| | Leg | 2 | 2021 | 240 | 0.170 |
Why?
| | Walking | 3 | 2015 | 557 | 0.170 |
Why?
| | Syndrome | 1 | 2021 | 379 | 0.170 |
Why?
| | Male | 19 | 2021 | 71500 | 0.160 |
Why?
| | Prosthesis Design | 2 | 2014 | 352 | 0.160 |
Why?
| | Neck | 2 | 2017 | 107 | 0.160 |
Why?
| | Radiography | 2 | 2014 | 846 | 0.160 |
Why?
| | Exercise Therapy | 2 | 2015 | 459 | 0.150 |
Why?
| | Diabetes Complications | 1 | 2021 | 222 | 0.150 |
Why?
| | Cardiology | 1 | 2022 | 287 | 0.150 |
Why?
| | Vascular Diseases | 1 | 2022 | 246 | 0.150 |
Why?
| | Radiography, Interventional | 2 | 2011 | 129 | 0.150 |
Why?
| | Specialization | 1 | 2020 | 135 | 0.150 |
Why?
| | Reproducibility of Results | 3 | 2020 | 3380 | 0.150 |
Why?
| | Aorta | 1 | 2021 | 433 | 0.150 |
Why?
| | Acute Disease | 1 | 2021 | 1015 | 0.140 |
Why?
| | Reperfusion | 1 | 2018 | 46 | 0.140 |
Why?
| | Risk Factors | 6 | 2021 | 10644 | 0.140 |
Why?
| | Regional Blood Flow | 1 | 2020 | 504 | 0.140 |
Why?
| | Postoperative Complications | 3 | 2020 | 2887 | 0.140 |
Why?
| | Time Factors | 7 | 2020 | 7031 | 0.140 |
Why?
| | Randomized Controlled Trials as Topic | 1 | 2024 | 1671 | 0.130 |
Why?
| | Upper Extremity | 1 | 2018 | 110 | 0.130 |
Why?
| | Marfan Syndrome | 1 | 2017 | 45 | 0.130 |
Why?
| | Counseling | 2 | 2017 | 398 | 0.120 |
Why?
| | Heart Failure | 1 | 2009 | 2131 | 0.120 |
Why?
| | Female | 16 | 2021 | 77251 | 0.120 |
Why?
| | Colorado | 6 | 2018 | 4658 | 0.120 |
Why?
| | Patient Readmission | 1 | 2021 | 706 | 0.120 |
Why?
| | Aortic Aneurysm, Thoracic | 1 | 2017 | 136 | 0.110 |
Why?
| | Retrospective Studies | 9 | 2021 | 16741 | 0.110 |
Why?
| | Cardiovascular System | 1 | 2016 | 137 | 0.110 |
Why?
| | Life Style | 1 | 2017 | 483 | 0.110 |
Why?
| | Exercise Test | 2 | 2015 | 624 | 0.110 |
Why?
| | Medicare | 1 | 2020 | 811 | 0.110 |
Why?
| | Ultrasonography, Doppler, Color | 1 | 2014 | 37 | 0.110 |
Why?
| | Rupture | 1 | 2014 | 88 | 0.100 |
Why?
| | Alloys | 1 | 2014 | 38 | 0.100 |
Why?
| | Critical Illness | 1 | 2020 | 869 | 0.100 |
Why?
| | Double-Blind Method | 1 | 2018 | 2017 | 0.100 |
Why?
| | Acute Kidney Injury | 1 | 2021 | 831 | 0.100 |
Why?
| | Comorbidity | 3 | 2017 | 1678 | 0.100 |
Why?
| | Ultrasonography, Interventional | 1 | 2014 | 158 | 0.090 |
Why?
| | Survival Analysis | 1 | 2015 | 1332 | 0.090 |
Why?
| | California | 3 | 2018 | 467 | 0.090 |
Why?
| | Evidence-Based Medicine | 1 | 2015 | 724 | 0.090 |
Why?
| | Internship and Residency | 1 | 2022 | 1250 | 0.090 |
Why?
| | Blood Vessel Prosthesis Implantation | 1 | 2014 | 222 | 0.090 |
Why?
| | Vascular Patency | 1 | 2011 | 112 | 0.080 |
Why?
| | Practice Patterns, Physicians' | 1 | 2020 | 1362 | 0.080 |
Why?
| | Creatinine | 2 | 2009 | 494 | 0.080 |
Why?
| | Logistic Models | 2 | 2018 | 2107 | 0.080 |
Why?
| | Coronary Restenosis | 1 | 2009 | 21 | 0.080 |
Why?
| | Diastole | 1 | 2009 | 141 | 0.080 |
Why?
| | Artifacts | 1 | 2009 | 136 | 0.070 |
Why?
| | Equipment Design | 1 | 2010 | 533 | 0.070 |
Why?
| | United States | 4 | 2020 | 15553 | 0.070 |
Why?
| | Drug Therapy, Combination | 1 | 2011 | 1058 | 0.070 |
Why?
| | Myocardial Infarction | 1 | 2015 | 1072 | 0.070 |
Why?
| | Aged, 80 and over | 3 | 2021 | 8072 | 0.070 |
Why?
| | Practice Guidelines as Topic | 1 | 2015 | 1557 | 0.070 |
Why?
| | Movement | 1 | 2009 | 291 | 0.060 |
Why?
| | Incidence | 3 | 2021 | 2844 | 0.060 |
Why?
| | Prognosis | 2 | 2017 | 4152 | 0.060 |
Why?
| | Recurrence | 2 | 2020 | 1114 | 0.060 |
Why?
| | Severity of Illness Index | 1 | 2014 | 2936 | 0.060 |
Why?
| | Graft Rejection | 1 | 2009 | 551 | 0.060 |
Why?
| | Biomarkers | 3 | 2014 | 4241 | 0.050 |
Why?
| | Software | 1 | 2009 | 687 | 0.050 |
Why?
| | Kaplan-Meier Estimate | 2 | 2017 | 921 | 0.050 |
Why?
| | Sensitivity and Specificity | 1 | 2008 | 1984 | 0.050 |
Why?
| | Atrial Fibrillation | 1 | 2009 | 508 | 0.050 |
Why?
| | Heart Transplantation | 1 | 2009 | 726 | 0.050 |
Why?
| | Age Factors | 1 | 2009 | 3328 | 0.040 |
Why?
| | Body Mass Index | 1 | 2009 | 2429 | 0.040 |
Why?
| | Administrative Claims, Healthcare | 1 | 2020 | 26 | 0.040 |
Why?
| | Cardiologists | 1 | 2020 | 46 | 0.040 |
Why?
| | Registries | 2 | 2021 | 2238 | 0.040 |
Why?
| | Radiologists | 1 | 2020 | 62 | 0.040 |
Why?
| | Ambulatory Surgical Procedures | 1 | 2020 | 77 | 0.040 |
Why?
| | Extremities | 1 | 2020 | 141 | 0.040 |
Why?
| | Hospitalization | 2 | 2020 | 2313 | 0.040 |
Why?
| | Retreatment | 1 | 2018 | 75 | 0.040 |
Why?
| | Ultrasonography, Doppler, Duplex | 1 | 2017 | 40 | 0.030 |
Why?
| | Aneurysm, False | 1 | 2017 | 45 | 0.030 |
Why?
| | Obesity | 1 | 2009 | 3041 | 0.030 |
Why?
| | Head | 1 | 2017 | 122 | 0.030 |
Why?
| | Computed Tomography Angiography | 1 | 2017 | 141 | 0.030 |
Why?
| | Surgeons | 1 | 2020 | 336 | 0.030 |
Why?
| | Ambulatory Care | 1 | 2020 | 601 | 0.030 |
Why?
| | Curriculum | 1 | 2022 | 1047 | 0.030 |
Why?
| | Intention to Treat Analysis | 1 | 2015 | 77 | 0.030 |
Why?
| | Databases, Factual | 1 | 2020 | 1465 | 0.030 |
Why?
| | Clinical Competence | 1 | 2022 | 1235 | 0.030 |
Why?
| | Disease-Free Survival | 1 | 2015 | 720 | 0.020 |
Why?
| | Heart | 1 | 2017 | 632 | 0.020 |
Why?
| | Exercise Tolerance | 1 | 2015 | 285 | 0.020 |
Why?
| | Follow-Up Studies | 2 | 2015 | 5308 | 0.020 |
Why?
| | Physical Endurance | 1 | 2014 | 278 | 0.020 |
Why?
| | Quality of Life | 2 | 2015 | 3080 | 0.020 |
Why?
| | Delivery of Health Care, Integrated | 1 | 2015 | 293 | 0.020 |
Why?
| | Surgical Wound Infection | 1 | 2015 | 328 | 0.020 |
Why?
| | Proportional Hazards Models | 1 | 2015 | 1292 | 0.020 |
Why?
| | Adult | 2 | 2017 | 40013 | 0.020 |
Why?
| | Recovery of Function | 1 | 2015 | 702 | 0.020 |
Why?
| | Activities of Daily Living | 1 | 2014 | 429 | 0.020 |
Why?
| | Feasibility Studies | 1 | 2015 | 1051 | 0.020 |
Why?
| | Program Evaluation | 1 | 2015 | 937 | 0.020 |
Why?
| | Patient Compliance | 1 | 2015 | 617 | 0.020 |
Why?
| | Survival Rate | 1 | 2015 | 2003 | 0.020 |
Why?
| | Clinical Trials as Topic | 1 | 2014 | 1043 | 0.020 |
Why?
| | Pilot Projects | 1 | 2015 | 1838 | 0.020 |
Why?
| | Endocardium | 1 | 2009 | 31 | 0.020 |
Why?
| | Phenotype | 1 | 2017 | 3211 | 0.020 |
Why?
| | Statistics as Topic | 1 | 2009 | 298 | 0.020 |
Why?
| | Oxidative Stress | 1 | 2014 | 1370 | 0.020 |
Why?
| | Stroke Volume | 1 | 2009 | 607 | 0.010 |
Why?
| | Ventricular Function, Left | 1 | 2009 | 520 | 0.010 |
Why?
| | Biopsy | 1 | 2009 | 1083 | 0.010 |
Why?
| | Hemodynamics | 1 | 2009 | 1117 | 0.010 |
Why?
| | Myocardium | 1 | 2009 | 928 | 0.010 |
Why?
| | Surveys and Questionnaires | 1 | 2015 | 6025 | 0.010 |
Why?
|
|
Rogers's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|